CDK20: Cyclin Dependent Kinase 20

A cell cycle regulator and potential oncogene in hepatocellular carcinoma

Gene Information Card

Symbol CDK20
Full Name Cyclin Dependent Kinase 20
Gene Type Protein coding
Chromosomal Location 9q22.1
NCBI Gene ID 23552 ncbi.nlm.nih.gov/gene/23552
Ensembl ID ENSG00000107104
UniProt ID Q8IZL9
OMIM ID 611447
HGNC ID 20287
Aliases CCRK, P42, bA864N19.2, cell cycle related kinase

Description

CDK20 (Cyclin Dependent Kinase 20), also known as CCRK (Cell Cycle Related Kinase), is a protein-coding gene that encodes a member of the cyclin-dependent kinase family. The protein is involved in cell cycle regulation, particularly in the G1/S transition, and has been implicated in ciliary function and hepatocellular carcinoma progression. CDK20 interacts with cyclin H and CDK7 to activate CDK2, and is also required for proper ciliogenesis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatocellular carcinoma CDK20 overexpression promotes cell proliferation and tumor growth via activation of CDK2 and Rb phosphorylation PMID: 20010866
Orofacial cleft 12 Homozygous missense variant in CDK20 associated with cleft lip/palate PMID: 28132692
Primary microcephaly Loss-of-function mutations in CDK20 impair centriole duplication and cause microcephaly PMID: 28132692

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Liver 6.8 Low
Brain 4.2 Low
Kidney 3.9 Low
Heart 2.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 8.5 Hepatocellular carcinoma cell line
HEK293 6.2 Embryonic kidney cells
HeLa 5.0 Cervical cancer cells
A549 4.1 Lung carcinoma cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.832C>T (p.Arg278Cys) Missense Rare Loss of function; associated with orofacial cleft and microcephaly
c.1A>G (p.Met1Val) Start loss Rare Loss of function; associated with primary microcephaly
c.715G>A (p.Gly239Arg) Missense Rare Likely damaging; reported in ClinVar
Mutation functional classification

Loss of Function (LOF)

Missense and start-loss mutations in CDK20 impair kinase activity and centriole duplication, leading to microcephaly and orofacial clefts.

Gain of Function (GOF)

Overexpression of wild-type CDK20 in hepatocellular carcinoma acts as an oncogene by promoting cell cycle progression.

Dominant Negative (DN)

Not reported for CDK20.

Pathways

Cell Cycle (KEGG: hsa04110)
Cilium Assembly (Reactome: R-HSA-5620912)
CDK-mediated phosphorylation and removal of Cdc6 (Reactome: R-HSA-69017)

Protein Summary

CDK20 encodes a 42 kDa serine/threonine protein kinase (UniProt Q8IZL9) that localizes to the nucleus and centrosome. It contains a typical kinase domain and is essential for cell cycle progression through G1/S transition. CDK20 forms a complex with cyclin H and CDK7 to phosphorylate and activate CDK2. Additionally, it plays a critical role in ciliogenesis by regulating centriole duplication. Mutations in CDK20 cause autosomal recessive primary microcephaly and orofacial clefting, while overexpression is oncogenic in hepatocellular carcinoma.

Related Products

Product name Cat.No. Species Gene ID
CDK20 Knockout HEK293 Cell Line EDJ-KQ8070 Human 23552 Details Get a Quote
CDK20 Knockout A-549 Cell Line EDJ-KQ32559 Human 23552 Details Get a Quote
CDK20 Knockout HCT 116 Cell Line EDJ-KQ33900 Human 23552 Details Get a Quote
CDK20 Knockout HeLa Cell Line EDJ-KQ33901 Human 23552 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: